Tissue targeting of anti-RNP autoimmunity: Effects of T cells and myeloid dendritic cells in a murine model

Arthritis and Rheumatism

Volumn 60, Issue 2, 2009, Pages 534-542

  Greidinger, Eric L ^a,d   Zang, Yunjuan ^a   Fernandez, Irina ^b   Berho, Mariana ^c   Nassiri, Mehdi ^a   Martinez, Laisel ^a   Hoffman, Robert W ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Miami VA Foundation for Medical Research   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RIBONUCLEOPROTEIN ANTIBODY;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CELL TRANSFER; CONTROLLED STUDY; DENDRITIC CELL; GLOMERULONEPHRITIS; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEINURIA; SPLEEN CELL;

ADOPTIVE TRANSFER; ANIMALS; AUTOIMMUNITY; CD4-POSITIVE T-LYMPHOCYTES; CELL TRANSPLANTATION; CELLS, CULTURED; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; GLOMERULONEPHRITIS; LUNG DISEASES, INTERSTITIAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID CELLS; PROTEINURIA; RIBONUCLEOPROTEIN, U1 SMALL NUCLEAR; SPLEEN; T-LYMPHOCYTES;

EID: 59649098269     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.24256     Document Type: Article

References (27)

1. Sharp GC, Irvin WS, May CM, Holman HR, McDuffie FC, Hess EV, et al. Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systematic lupus erythematosus and other rheumatic diseases. N Engl J Med 1976;295:1149-54.
2. Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003;349:1526-33.
3. Greidinger EL, Hoffman RW. The appearance of U1 RNP antibody specificities in sequential autoimmune human antisera follows a characteristic order that implicates the U1-70 kd and B′/B proteins as predominant U1 RNP immunogens. Arthritis Rheum 2001;44:368-75.
4. Greidinger EL, Zang YJ, Jaimes K, Hogenmiller S, Nassiri M, Bejarano P, et al. A murine model of mixed connective tissue disease induced with U1 small nuclear RNP autoantigen. Arthritis Rheum 2006;54:661-9.
5. -/- mice. Autoimmunity 2007;40:208-16.
6. Fatenejad S, Mamula MJ, Craft J. Role of intermolecular/intrastructural B- and T-cell determinants in the diversification of autoantibodies to ribonucleoprotein particles. Proc Natl Acad Sci U S A 1993;90:12010-4.
7. Wang D, Hill JA, Jevnikar AM, Cairns E, Bell DA. Induction of transient arthritis by the adoptive transfer of a collagen II specific Th1 clone to HLA-DR4 (B1*0401) transgenic mice. J Autoimmun 2002;19:37-43.
8. Greidinger EL, Zang YJ, Jaimes K, Martinez L, Nassiri M, Hoffman RW. CD4+ T cells target epitopes residing within the RNA binding domain of the U1-70kD small nuclear ribonucleoprotein autoantigen and have restricted TCR diversity in an HLA-DR4 transgenic murine model of mixed connective tissue disease. J Immunol 2008;180:8444-54.
9. Hoffman RW, Takeda Y, Sharp GC, Lee DR, Hill DL, Kaneoka H, et al. Human T cell clones reactive against U-small nuclear ribonucleoprotein autoantigens from connective tissue disease patients and healthy individuals. J Immunol 1993;151:6460-9.
10. Holyst MM, Hill DL, Hoch SO, Hoffman RW. Analysis of human T cell and B cell responses against U small nuclear ribonucleoprotein 70-kd, B and D polypeptides among patients with systemic lupus erythematosus and mixed connective tissue disease. Arthritis Rheum 1997;40:1493-503.
11. Greidinger EL, Gazitt T, Jaimes KF, Hoffman RW. Human T cell clones specific for heterogeneous nuclear ribonucleoprotein A2 autoantigen from connective tissue disease patients assist in autoantibody production. Arthritis Rheum 2004:50:2216-22.
12. Greidinger EL, Foecking MF, Schafermeyer KR, Bailey CW, Primm SL, Lee DR, et al. T cell immunity in connective tissue disease patients targets the RNA binding domain of the U1-70kDa small nuclear ribonucleoprotein. J Immunol 2002;169:3429-37.
13. Greidinger EL, Zang YJ, Martinez L, Jaimes K, Nassiri M, Bejarano P, et al. Differential tissue targeting of autoimmunity manifestations by autoantigen-associated Y RNAs. Arthritis Rheum 2007;56:1589-97.
14. Greidinger EL, Foecking MF, Magee J, Wilson L, Ranatunga S, Ortmann RA, et al. A major B cell epitope present on the apoptotic but not the intact form of the U1-70-kDa ribonucleoprotein autoantigen. J Immunol 2004;172:709-16.
15. Edwards AD, Diebold SS, Slack EM, Tomizawa H, Hemmi H, Kaisho T, et al. Toll-like receptor expression in murine DC subsets: lack of TLR7 expression by CD8 alpha+ DC correlates with unresponsiveness to imidazoquinolines. Eur J Immunol 2003;33:827-33.
16. Banchereau J, Pascual V. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 2006;25:383-92.
17. Bodolay E, Szekanecz Z, Devenyi K, Galuska L, Csipo I, Vegh J, et al. Evaluation of interstitial lung disease in mixed connective tissue disease (MCTD). Rheumatology (Oxford) 2005;44:656-61.
18. Le Goffic R, Pothlichet J, Vitour D, Fujita T, Meurs E, Chignard M, et al. Cutting edge: influenza A virus activates TLR3-dependent inflammatory and RIG-I-dependent antiviral responses in human lung epithelial cells. J Immunol 2007;178:3368-72.
19. Rudd BD, Smit JJ, Flavell RA, Alexopoulou L, Schaller MA, Gruber A, et al. Deletion of TLR3 alters the pulmonary immune environment and mucus production during respiratory syncytial virus infection. J Immunol 2006;176:1937-42.
20. Camateros P, Tamaoka M, Hassan M, Marino R, Moisan J, Marion D, et al. Chronic asthma-induced airway remodeling is prevented by Toll-like receptor-7/8 ligand S28463. Am J Respir Crit Care Med 2007;175:1241-9.
21. Demedts IK, Bracke KR, Maes T, Joos GF, Brusselle GG. Different roles for human lung dendritic cell subsets in pulmonary immune defense mechanisms. Am J Respir Cell Mol Biol 2006;35:387-93.
22. Kato A, Favoreto S Jr, Avila PC, Schleimer RP. TLR3- and Th2 cytokine-dependent production of thymic stromal lymphopoietin in human airway epithelial cells. J Immunol 2007;179:1080-7.
23. Jeon SG, Oh SY, Park HK, Kim YS, Shim EJ, Lee HS, et al. TH2 and TH1 lung inflammation induced by airway allergen sensitization with low and high doses of double-stranded RNA. J Allergy Clin Immunol 2007;120:803-12.
24. Christensen SR, Shupe J, Nickerson K, Kashgarian M, Flavell RA, Shlomchik MJ. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 2006;25:417-28.
25. Smolen JS, Steiner G. Mixed connective tissue disease: to be or not to be? [review]. Arthritis Rheum 1998;41:768-77.
26. Sharp GC, Hoffman RW. Clinical, immunologic, and immunogenetic evidence that mixed connective tissue disease is a distinct entity: comment on the article by Smolen and Steiner [letter]. Arthritis Rheum 1999;42:190-1.
27. Isenberg D, Black C. Naming names! Comment on the article by Smolen and Steiner [letter]. Arthritis Rheum 1999;42:191-3.